FOXO3a predicts for survival and its phosphorylated form is downregulated following mTOR or MEK inhibitor therapy in Hepatocellular Carcinoma Performance status 0 (n=42) (vs. PS 2) 0.19 0.05 - 0.72 ...
Comparative outcomes of systemic therapy vs. locoregional therapies in hepatocellular carcinoma with portal vein thrombosis. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This ...
This case describes a presentation of a patient with clinical features of acromegaly, elevated growth hormone (GH) concentrations, a pituitary adenoma but with normal insulin-like growth factor-1 (IGF ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The PATHFNDR-2 trial enrolled adults with acromegaly who ...
The growth factor IGF plays a key role in human growth. In the absence of IGF signaling, we become dwarfs. Later in life, IGF is involved in age-related diseases, e.g. cancer and cardiovascular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results